Insight

Ramy Sedhom: Older adults are underrepresented in clinical trials and receive treatment with limited data on tolerability

Photo from Ramy Sedhom/X

Feb 28, 2024, 19:14

Ramy Sedhom: Older adults are underrepresented in clinical trials and receive treatment with limited data on tolerability

Ramy Sedhom, Medical Oncologist and

”This work needs more attention! Older adults are underrepresented in clinical trials and receive treatment with limited data on tolerability.

Mentee of Supriya Mohile shows primary dose reduction improves treatment tolerability among older adults with advanced cancer and age-related conditions.”

Read further.
Source: Ramy Sedhom/X

advanced cancer cancer clinical trials OncoDaily Oncology primary dose reduction Ramy Sedhom Supriya Mohile treatment tolerability among older adults underrepresentation in clinical trials

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage